Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients-Reference-Cited by-同舟云学术

Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients

Published:2016-02-24 Issue:2 Volume:11 Page:e0149509
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nagata Eiichiro,Ogino Mieko,Iwamoto Kounosuke,Kitagawa Yasuhisa,Iwasaki Yasuo,Yoshii Fumihito,Ikeda Joh-E.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Amyotrophic lateral sclerosis;LP Rowland,2001

2. Amyotrophic lateral sclerosis: problems and prospects;J Sreedharan,2013

3. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target;SC Barber,2006

4. ALS: a disease of motor neurons and their nonneuronal neighbors;S Boillee,2006

5. Molecular biology of amyotrophic lateral sclerosis from genetics;P Pasinelli,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction;Molecules;2024-07-29

2. A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models;Nature Communications;2024-07-15

3. Synthesis and Biological Analysis of Iso-dimethyltryptamines in a Model of Light-Induced Retinal Degeneration;ACS Medicinal Chemistry Letters;2024-06-13

4. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies;European Journal of Medicinal Chemistry;2024-06

5. Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis;Reviews in the Neurosciences;2024-02-22